Physician profile
Allison A Smith
NPI 1427521202
$4,048.72
in general payments reported to CMS, 2019-2025
13 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,906 · 2022: $377 · 2023: $246 · 2024: $360 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,834.00 | 2021 | |
| Medical Device Business Services, INC. | $236.07 | 2022-2025 | Vistaseal |
| Amgen INC. | $232.31 | 2024 | Evenity |
| Smith+Nephew, INC. | $183.97 | 2023-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Stravix, Grafix |
| Ethicon US, LLC | $167.73 | 2022-2023 | Vistaseal, Surgicel Nu-Knit, Ethicon |
| Bioventus LLC | $113.97 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $86.32 | 2023-2024 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $61.17 | 2025 | |
| Horizon Therapeutics Plc | $58.01 | 2021-2022 | |
| Pacira Therapeutics, INC. | $24.95 | 2021 | |
| Heron Therapeutics, INC. | $20.67 | 2023 | Zynrelef |
| Vericel Corporation | $17.45 | 2021 | |
| Fidia Pharma USA INC. | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.